Why is Solara Active falling/rising?

As of 06-Nov, Solara Active Pharma Sciences Ltd is experiencing a decline in its stock price, currently at Rs 564.75, which represents a decrease of Rs 52.65 or 8.53%. The stock has underperformed its sector by 7.76% today and has been on a downward trend for the last two days, accumulating a total loss of 10.63%. It opened significantly lower, with an initial drop of 8.49%, and reached an intraday low of Rs 542.95, marking a decline of 12.06%. Over the past week, the stock has fallen by 6.51%, and its performance over the last year shows a substantial decline of 30.71%. Despite a notable increase in profits by 101.8% over the past year, the stock's overall performance has been hindered by weak long-term fundamentals, including a negative growth rate in operating profits and a high debt-to-EBITDA ratio.
In the broader market context, Solara's recent performance contrasts sharply with the benchmark Sensex, which has gained 1.86% over the past month. The stock's significant underperformance is evident as it has generated a return of -16.45% year-to-date, while the Sensex has increased by 6.62% during the same period. The company's weak financial indicators, such as a low return on equity and a high percentage of pledged promoter shares, further contribute to the downward pressure on its stock price, especially in a falling market. Overall, the combination of poor short-term performance relative to the benchmark and concerning financial metrics has led to the stock's decline.